The bioconvergence market has experienced rapid growth, with predictions of reaching $159.66 billion in 2025 and $243.53 billion in 2029. This growth is fueled by personalized medicine, biomedical engineering advancements, and increased healthcare digitization. Innovative trends like AI in drug discovery and lab-on-a-chip technologies are shaping the industry. Major drivers include the emphasis on personalized […]
Category: Anima Biotech
Innovations by Anima Biotech Inc.
In the rapidly evolving biotech sector, the star that is currently shining brightest belongs to Anima Biotech Inc. This dynamic company is rewriting the rules of innovative drug development, setting a new benchmark in its pursuit of novel therapies. The company’s central strategy is to harness advanced technologies to target RNA for the treatment of […]
